Connor, Clark & Lunn Investment Management (CC&L)
ONCS

Connor, Clark & Lunn Investment Management (CC&L)’s OncoSec Medical Incorporated ONCS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67
Closed -$18K – 1056
2016
Q4 		$18K Buy
+67
New +$23K ﹤0.01% 871

Other funds holding ONCS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFEC
First Financial Equity Corporation Scottsdale, Arizona $584M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ONCS Position: Q1 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of OncoSec Medical Incorporated (ONCS) in Q1 2017, closing a stake of 67 shares — an estimated $18K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ONCS in Q4 2016 and held it in 1 quarter. The position peaked at $18K in Q4 2016. 21 funds tracked by Wall St. Rank hold ONCS as of Q1 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining OncoSec Medical Incorporated position as of Q1 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 67 OncoSec Medical Incorporated shares in Q1 2017, an estimated $18K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OncoSec Medical Incorporated in Q4 2016 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s OncoSec Medical Incorporated position peaked at $18K in Q4 2016.
  • 21 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2017, filed 15 May 2017.